Before joining moksha8, Mr. Howarth was Chief Business Officer at Vitae Pharmaceuticals leading commercial, business development and legal. While at Vitae, Mr. Howarth led the two key strategic alliances with GSK ($175MM) and Boehringer Ingelheim ($336MM) to advance development of its hypertension and diabetes programs.. Prior to joining Vitae,. Mr. Howarth was Head, Venture Partnerships at GlaxoSmithKline plc (GSK) where he led a team focused on generating value by partnering GSK clinical assets globally. As part of the Worldwide Business Development group, Mr. Howarth executed numerous licensing transactions totaling over $2BB in deal valuations across all phases of development and in a variety of therapeutic areas. Prior to joining GSK, Mr. Howarth worked at KPMG, where he qualified as a chartered accountant.. Mr. Howarth received his BSc in Biochemistry from the University of Bath, United Kingdom and conducted molecular biology and neuroscience research at Celltech and Merck. Mr. Howarth has worked in three countries on three continents and speaks two languages.
